No Data
No Data
No Data
No Data
No Data
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
Novel Supplement Shown to Address Signs and Symptoms of Dry Eyes, All Primary Endpoints Achieved Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live
BusinesswireApr 25 20:30
Royal Bank of Canada: Maintaining the Bausch & Lomb (BLCO.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $20.00 to $18.00.
Royal Bank of Canada: Maintaining the Bausch & Lomb (BLCO.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $20.00 to $18.00.
Zhitong FinanceApr 22 23:40
RBC Capital Maintains Outperform on Bausch & Lomb, Lowers Price Target to $18
RBC Capital analyst Douglas Miehm maintains Bausch & Lomb (NYSE:BLCO) with a Outperform and lowers the price target from $20 to $18.
BenzingaApr 22 23:39
Bausch + Lomb Q1 Results Likely to Be Impacted by Foreign Exchange Headwinds, RBC Says
Bausch + Lomb's (BLCO) Q1 financial results are expected to be affected by continued foreign exchange headwinds, RBC Capital Markets said Monday. The eye health company is scheduled to report Q1 resul
MT NewswiresApr 22 22:50
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE and Biotrue Eye Care Recycling programs have
BusinesswireApr 18 19:00
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2024 financial results on Wednesday, May 1, 2024. Bausch +
BusinesswireApr 16 00:00
No Data
No Data